← All trials
NCT06216938
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 2, 2024
- Primary completion
- Jan 31, 2026
- Completion date
- Jul 31, 2028
- First posted
- Jan 22, 2024
- Last posted
- Mar 4, 2024
- Enrollment
- 25
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of PittsburghLead sponsor
- University of PittsburghSponsor investigator
- Replimune Inc.Collaborator
- University of PittsburghOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.